Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts

被引:28
|
作者
Castro, Victor M. [1 ,2 ]
McCoy, Thomas H. [1 ]
Perlis, Roy H. [1 ]
机构
[1] Massachusetts Gen Hosp, Ctr Quantitat Hlth, Div Clin Res, 185 Cambridge St,6th Floor, Boston, MA 02114 USA
[2] Mass Gen Brigham, Res Informat Sci & Comp, Somerville, MA USA
关键词
COVID-19;
D O I
10.1001/jamanetworkopen.2020.23934
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance The coronavirus disease 2019 (COVID-19) pandemic has placed unprecedented stress on health systems across the world, and reliable estimates of risk for adverse hospital outcomes are needed. Objective To quantify admission laboratory and comorbidity features associated with critical illness and mortality risk across 6 Eastern Massachusetts hospitals. Design, Setting, and Participants Retrospective cohort study of all individuals admitted to the hospital who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by polymerase chain reaction across these 6 hospitals through June 5, 2020, using hospital course, prior diagnoses, and laboratory values in emergency department and inpatient settings from 2 academic medical centers and 4 community hospitals. The data were extracted on June 11, 2020, and the analysis was conducted from June to July 2020. Exposures SARS-CoV-2. Main Outcomes and Measures Severe illness defined by admission to intensive care unit, mechanical ventilation, or death. Results Of 2511 hospitalized individuals who tested positive for SARS-CoV-2 (of whom 50.9% were male, 53.9% White, and 27.0% Hispanic, with a mean [SD ]age of 62.6 [19.0] years), 215 (8.6%) were admitted to the intensive care unit, 164 (6.5%) required mechanical ventilation, and 292 (11.6%) died. L1-regression models developed in 3 of these hospitals yielded an area under the receiver operating characteristic curve of 0.807 for severe illness and 0.847 for mortality in the 3 held-out hospitals. In total, 212 of 292 deaths (72.6%) occurred in the highest-risk mortality quintile. Conclusions and Relevance In this cohort, specific admission laboratory studies in concert with sociodemographic features and prior diagnosis facilitated risk stratification among individuals hospitalized for COVID-19. Question How well can sociodemographic features, laboratory values, and comorbidities of individuals hospitalized with coronavirus disease 2019 (COVID-19) in Eastern Massachusetts through June 5, 2020, predict a severe illness course? Findings In this cohort study of 2511 hospitalized individuals positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by polymerase chain reaction who were admitted to 1 of 6 hospitals, 215 (8.6%) were admitted to the instensive care unit, 164 (6.5%) required mechanical ventilation, and 292 (11.6%) died. In a risk prediction model, 212 deaths (78%) occurred in the top mortality-risk quintile. Meaning Simple prediction models may assist in risk stratification among hospitalized patients with COVID-19. This cohort study assesses admission laboratory and comorbidity features associated with critical illness and mortality risk among patients hospitalized with coronavirus disease 2019 (COVID-19) across 6 Eastern Massachusetts hospitals.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Cardiac involvement according to echocardiographic findings in severe coronavirus disease 2019
    Tajmirriahi, Marzieh
    Salmasi, Mehrzad
    Soltaninejad, Forogh
    Amra, Babak
    Sami, Ramin
    Naderi, Zohreh
    ARYA ATHEROSCLEROSIS, 2021, 17
  • [32] Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019 The Ivermectin in COVID Nineteen Study
    Rajter, Juliana Cepelowicz
    Sherman, Michael S.
    Fatteh, Naaz
    Vogel, Fabio
    Sacks, Jamie
    Rajter, Jean-Jacques
    CHEST, 2021, 159 (01) : 85 - 92
  • [33] Management of Patients With Severe Mental Illness During the Coronavirus Disease 2019 Pandemic
    Kahl, Kai G.
    Correll, Christoph U.
    JAMA PSYCHIATRY, 2020, 77 (09) : 977 - 978
  • [34] Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020
    Gupta, Nivedita
    Praharaj, Ira
    Bhatnagar, Tarun
    Thangaraj, Jeromie Wesley Vivian
    Giri, Sidhartha
    Chauhan, Himanshu
    Kulkarni, Sanket
    Murhekar, Manoj
    Singh, Sujeet
    Gangakhedkar, Raman R.
    Bhargava, Balram
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 151 (2-3) : 236 - 240
  • [35] Acute kidney injury is associated with the mortality of coronavirus disease 2019
    Wang, Ying
    Shi, Li
    Yang, Haiyan
    Duan, Guangcai
    Wang, Yadong
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2335 - 2337
  • [36] Coronavirus disease 2019 pandemic: Do not forget patients with severe mental illness
    Mousavi, S. Bentolhoda
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 2021, 67 (07) : 830 - 832
  • [37] Cardiovascular drugs and analysis of potential risk factors associated with mortality in severe coronavirus disease 2019 patients
    Atabey, Rukiye Derin
    Aladag, Nesim
    Sipal, Abdulcebbar
    Akbulut, Tayyar
    Dogan, Zeki
    Ozdemir, Mahmut
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (02): : 176 - 182
  • [38] Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'
    Tang, Ning
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (06) : 1520 - 1521
  • [39] How Do Presenting Symptoms and Outcomes Differ by Race/Ethnicity Among Hospitalized Patients With Coronavirus Disease 2019 Infection? Experience in Massachusetts
    McCarty, Thomas R.
    Hathorn, Kelly E.
    Redd, Walker D.
    Rodriguez, Nicolette J.
    Zhou, Joyce C.
    Bazarbashi, Ahmad Najdat
    Njie, Cheikh
    Wong, Danny
    Quoc-Dien Trinh
    Shen, Lin
    Stone, Valerie E.
    Chan, Walter W.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E4131 - E4138
  • [40] Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease
    Liu Wei
    Tao Zhao-Wu
    Wang Lei
    Yuan Ming-Li
    Liu Kui
    Zhou Ling
    Wei Shuang
    Deng Yan
    Liu Jing
    Liu Hui-Guo
    Yang Ming
    Hu Yi
    CHINESE MEDICAL JOURNAL, 2020, 133 (09) : 1032 - 1038